Krishna Institute of Medical Sciences · NSE: KIMS · BSE: 543308
Q2 FY23 results · Jul–Sep 2022
Krishna Institute of Medical Sciences reported revenue from operations of ₹564.07 crore (up 37.0% from Q2 FY22) and net profit of ₹106.07 crore (up 25.9% from Q2 FY22) for Q2 FY23 (Jul–Sep 2022), on a consolidated basis.
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 564.07 | 411.74 | +37.0% | 495.51 | +13.8% |
| Other income | 9.20 | 5.41 | +70.3% | 5.33 | +72.5% |
| Total income | 573.28 | 417.15 | +37.4% | 500.85 | +14.5% |
| Profit before tax | 137.47 | 113.16 | +21.5% | 107.36 | +28.0% |
| Net profit for the period | 106.07 | 84.25 | +25.9% | 79.25 | +33.8% |
| Attributable to shareholders of the company | 97.11 | 81.72 | +18.8% | 69.96 | +38.8% |
| EPS, basic (₹) | 12.14 | 10.34 | +17.5% | 8.74 | +38.9% |
| Net margin (%) | 18.8 | 20.5 | 16.0 |
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 292.21 | 284.17 | +2.8% | 262.95 | +11.1% |
| Other income | 7.63 | 9.34 | −18.3% | 3.71 | +105.9% |
| Total income | 299.84 | 293.51 | +2.2% | 266.66 | +12.4% |
| Profit before tax | 83.78 | 94.93 | −11.7% | 70.02 | +19.7% |
| Net profit for the period | 61.20 | 71.31 | −14.2% | 52.12 | +17.4% |
| EPS, basic (₹) | 7.65 | 8.91 | −14.1% | 6.51 | +17.5% |
| Net margin (%) | 20.9 | 25.1 | 19.8 |
Consolidated
- Filed with BSE
- 13 Nov 2022, 12:52 IST
- Board meeting
- 11 Nov 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 13 Nov 2022, 12:52 IST
- Board meeting
- 11 Nov 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE